Evidence map›Paper›PMID 35382504›Full record

ReviewJournal of scleroderma and related disorders2019

A review of exercise pulmonary hypertension in systemic sclerosis.

Faisal Shaikh, Zafia Anklesaria, Tasneam Shagroni, Rajeev Saggar, Luna Gargani, Eduardo Bossone, Michael Ryan, Richard Channick, Rajan Saggar

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of scleroderma and related disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Advances in the imaging of pulmonary hypertension.International journal of cardiology. Congenital heart disease · 2025
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Faisal ShaikhUniversity of California-Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0003-1610-6371
Zafia AnklesariaUniversity of California-Los Angeles, Los Angeles, CA, USA.
Tasneam ShagroniUniversity of California-Los Angeles, Los Angeles, CA, USA.
Rajeev SaggarBanner University Medical Center Phoenix, Phoenix, AZ, USA.
Luna GarganiInstitute of Clinical Physiology, National Research Council, Pisa, Italy.
Eduardo BossoneCardarelli Hosptial, Cardiology Division, Naples, Italy.
Michael RyanCentral Coast Chest Consultants, San Luis Obispo, CA, USA.
Richard ChannickUniversity of California-Los Angeles, Los Angeles, CA, USA.
Rajan SaggarUniversity of California-Los Angeles, Los Angeles, CA, USA.
University of California, Los Angeles · USIstituto di Fisiologia Clinica · ITOspedale Antonio Cardarelli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In general, pulmonary vascular disease has important negative prognostic implications, regardless of the associated condition or underlying mechanism. In this regard, systemic sclerosis is of particular interest as it is the most common connective tissue disease associated with pulmonary hypertension, and a well-recognized at-risk population. In the setting of systemic sclerosis and unexplained dyspnea, the concept of using exercise to probe for underlying pulmonary vascular disease has acquired significant interest. In theory, a diagnosis of systemic sclerosis-associated exercise pulmonary hypertension may allow for earlier therapeutic intervention and a favorable alteration in the natural history of the pulmonary vascular disease. In the context of underlying systemic sclerosis, the purpose of this article is to provide a comprehensive review of the evolving definition of exercise pulmonary hypertension, the current role and methodologies for non-invasive and invasive exercise testing, and the importance of the right ventricle.

Indexed as

Exercise pulmonary hypertensionpulmonary hypertensionpulmonary vascular diseasesclerodermasystemic sclerosis

Identifiers

PMID35382504
PMCPMC8922563
OpenAlexW2950086698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.